Africa is increasingly becoming an arena for geopolitical competition over its resources and, in the last two decades, has seen many emerging powers such as China, India, Russia, Japan and Brazil attempting to strengthen their ties with the continent. Turkey's involvement has been much less discussed, despite the fact that Turkey's strategic involvement with several sub-Saharan African states has been deepening since its active engagement in the Somali crisis of 2011. Federico Donelli brings to light the extent of Turkey's involvement in Africa and analyses the unique characteristics, benefits, challenges and limits of Turkish policy in the region. The book examines the Turkish diplomatic programme as well as its domestic reception, which includes humanitarian aid, religious links such as the OIC (Organisation of Islamic Cooperation), as well as private business links. Crucially, Donelli examines what makes Turkish involvement different from that of other international actors in the region – its historic ties with North Africa under the Ottoman Empire.
Africa is increasingly becoming an arena for geopolitical competition over its resources and, in the last two decades, has seen many emerging powers such as China, India, Russia, Japan and Brazil attempting to strengthen their ties with the continent. Turkey's involvement has been much less discussed, despite the fact that Turkey's strategic involvement with several sub-Saharan African states has been deepening since its active engagement in the Somali crisis of 2011. Federico Donelli brings to light the extent of Turkey's involvement in Africa and analyses the unique characteristics, benefits, challenges and limits of Turkish policy in the region. The book examines the Turkish diplomatic programme as well as its domestic reception, which includes humanitarian aid, religious links such as the OIC (Organisation of Islamic Cooperation), as well as private business links. Crucially, Donelli examines what makes Turkish involvement different from that of other international actors in the region – its historic ties with North Africa under the Ottoman Empire.
Comics are a pervasive art form and an intrinsic part of the cultural fabric of most countries. And yet, relatively little has been written on the translation of comics. Comics in Translation attempts to address this gap in the literature and to offer the first and most comprehensive account of various aspects of a diverse range of social practices subsumed under the label 'comics'. Focusing on the role played by translation in shaping graphic narratives that appear in various formats, different contributors examine various aspects of this popular phenomenon. Topics covered include the impact of globalization and localization processes on the ways in which translated comics are embedded in cultures; the import of editorial and publishing practices; textual strategies adopted in translating comics, including the translation of culture- and language-specific features; and the interplay between visual and verbal messages. Comics in translation examines comics that originate in different cultures, belong to quite different genres, and are aimed at readers of different age groups and cultural backgrounds, from Disney comics to Art Spiegelman's Maus, from Katsuhiro Ōtomo's Akira to Goscinny and Uderzo's Astérix. The contributions are based on first-hand research and exemplify a wide range of approaches. Languages covered include English, Italian, Spanish, Arabic, French, German, Japanese and Inuit. The volume features illustrations from the works discussed and an extensive annotated bibliography. Contributors include: Raffaella Baccolini, Nadine Celotti, Adele D'Arcangelo, Catherine Delesse, Elena Di Giovanni, Heike Elisabeth Jüngst, Valerio Rota, Carmen Valero-Garcés, Federico Zanettin and Jehan Zitawi.
Doxorubicin: Anticancer Antibiotics details the development of doxorubicin as a wide-spectrum antitumor antibiotic. The book begins by tracing the discovery and development of doxorubicin, highlighting factors such as (a) the involvement of organic chemistry at an early stage, which allowed the rapid identification of doxorubicin and ensured its prompt availability for the clinical trials; (b) the well-established, pioneering expertise in experimental chemotherapy of Professor Aurelio di Marco and his group at Istituto Nazionale Tumori, Milan; and (c) the highly motivated interest of experienced clinicians. The remaining chapters provide an overview of basic studies in the area of medicinal chemistry and related fields that have resulted from doxorubicin development. Such studies have been concerned with both biochemical and biophysical investigations at the molecular level and at different levels of biological organization. A large body of work aimed at developing synthetic procedures for the drug and for new related analogs of potential clinical usefulness has also been carried out.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.